Archives
-
WM-8014: A Mechanism-First KAT6A Guide
2026-10-01
WM-8014 is a reversible KAT6A inhibitor for dissecting acetyl-CoA-dependent chromatin regulation, senescence, and tumor-associated proliferation. This guide connects its biochemical mechanism with time-resolved assay design inspired by RESTRICT-seq, offering a practical framework for interpreting epigenetic phenotypes.
-
Sulfo-Cy5 NHS Ester for DC Assay Design
2026-10-01
Sulfo-Cy5 NHS ester enables solvent-conscious labeling for mechanistic dendritic-cell assays. This guide connects its aqueous-phase conjugation and far-red optical profile with experimental decisions inspired by nanostructure-enabled immune reprogramming.
-
Superoxide Dismutase Activity Assay Kit Guide
2026-09-30
Learn how the Superoxide Dismutase Activity Assay Kit converts superoxide dismutation into a quantitative colorimetric signal. This guide emphasizes assay boundaries, matrix controls, and lessons from probe-specific ROS measurement artifacts.
-
ATG4B Nuclear Translocation and AML DNA Repair
2026-09-30
The reference study identifies an energy-sensitive mechanism in which nuclear ATG4B binds PRMT1, suppresses MRE11 methylation, and weakens DNA repair in acute myeloid leukemia. Its combination of mechanistic cell biology, patient-derived material, genetically defined AML models, and xenograft studies supports ATG4B as a potential vulnerability, while also defining important limits for translation beyond leukemia.
-
Cy7 NHS Ester: Practical Labeling and Imaging Guide
2026-09-29
Cy7 NHS ester is a sulfonated, water-soluble NHS-ester dye for attaching near-infrared fluorescence to accessible amino groups on proteins and peptides. It is suited to aqueous labeling and near-infrared imaging, but it should not be selected when targets lack accessible amines or when labeled-dye solutions must be stored long term.
-
Kir2.1 Inhibition in Pulmonary Vascular Remodeling
2026-09-29
The reference study identifies Kir2.1 as a regulator of pulmonary artery smooth muscle cell proliferation and migration in experimental pulmonary hypertension. Using monocrotaline-induced disease modeling and PDGF-BB-stimulated human cells, it links Kir2.1 inhibition to suppression of the TGF-β1/SMAD2/3 pathway, OPN, and PCNA expression.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-28
Cy5 NHS ester(Et) is a water-soluble amine-reactive fluorescent reagent for covalently tagging proteins, peptides, and other biomolecules through primary amino groups. It supports protein labeling, immunofluorescence, flow cytometry, and fluorescence microscopy, but it is unsuitable for ethanol-based preparation and dissolved solutions should not be stored long term.
-
MTT Assay Guide for Reliable Cell Viability
2026-09-28
A practical, evidence-based guide to interpreting and optimizing MTT colorimetric cell viability assays, from signal limitations to reagent handling and vendor selection. It explains how MTT (SKU B7777) fits into reproducible in vitro workflows without treating metabolic activity as a direct cell count.
-
Matrine, YTHDF1, and Stemness in Thymoma Cells
2026-09-27
A 2026 in vitro study reports that Matrine reduces stemness-associated features and increases apoptosis in EL-4-B5 thymoma cells, with results implicating YTHDF1 and Wnt/β-catenin signaling. The findings offer a focused model for testing thymoma cell-state regulation, but do not establish an m6A-dependent mechanism or therapeutic efficacy in animals or patients.
-
Rotigotine hydrochloride in Viability Assays
2026-09-26
A practical guide to using Rotigotine hydrochloride (SKU A3777) in cell viability, cytotoxicity, and Parkinson’s disease research. It connects reported concentration ranges and handling information with assay controls, interpretation limits, and supplier-selection checks.
-
Cy7 NHS Ester: Practical Labeling and QC Guide
2026-09-25
Cy7 NHS ester is a water-soluble near-infrared label for attaching fluorescence to proteins, peptides, and other biomolecules with accessible amino groups. Use it to prepare purified conjugates for imaging workflows; it is not a standalone cell stain, and conjugate suitability for live systems must be tested in the intended model.
-
Withania somnifera Digestion Mapped by LC–MS/MS
2026-09-25
A 2026 LC–MS/MS study shows that digestive conditions can transform key Withania somnifera constituents differently: withaferin A and withanoside IV were comparatively labile, while withanolide A remained stable. By combining simulated gastrointestinal assays, targeted analysis, untargeted metabolomics, and molecular networking, the work highlights why botanical bioavailability studies should account for both compound identity and plant tissue.
-
WM-8014 and Time-Resolved Epigenetic Validation
2026-09-24
Time-gated CRISPR screening can distinguish resistance initiation from maintenance, while WM-8014 offers a chemical strategy for probing KAT6-linked growth control. This article connects the approaches without conflating their evidence and outlines practical, translationally minded study design.
-
Neuromedin S (rat): Practical GPCR Assay Guide
2026-09-24
Neuromedin S (rat) provides a defined peptide agonist for controlled studies of neuromedin U receptor signaling, with dossier-based guidance for solubility and storage. Use it in validated research workflows, not for diagnostic, therapeutic, clinical, or unsupported in vivo applications.
-
Partial BACE Inhibition Preserves Synaptic Transmission
2026-09-23
Satir and colleagues tested whether partial BACE inhibition can lower amyloid-β (Aβ) secretion without disrupting synaptic transmission in cultured rat cortical neurons. Across three inhibitors, reductions of less than 50% in Aβ secretion were not accompanied by detectable transmission deficits, whereas stronger inhibition was associated with decreased transmission—an important distinction for interpreting dose and exposure in Alzheimer’s disease research.